Vitiligo: vizsgálatok itt: Hongkong
1 trial · From ClinicalTrials.gov, checked 2026. november 13.. Ask the study team whether a trial fits you.
- 2/3. fázisTaking peopleTopical Ruxolitinib for Face and Neck Vitiligo of Adult Chinese Patients Refractory to Topical Tacrolimus
- Where
- Hong Kong
- Életkor
- 18 év to 85 év
- People
- 20
- Run by
- Hospital Authority, Hong Kong
See details and how to joinNCT06719024